Does Federally Funded Research Justify A Piece Of Pharma’s Profits?
Forbes: Drug Truths
MARCH 4, 2024
The thought that all drugs arise from government funded research is a fallacy.
Mon.Mar 04, 2024
221 
Researchers invent new triple-junction tandem solar cells with world-record efficiency
Science Daily: Pharmacology News
MARCH 4, 2024
Scientists have developed a novel triple-junction perovskite/Si tandem solar cell that can achieve a certified world-record power conversion efficiency of 27.1 per cent across a solar energy absorption area of 1 sq cm, representing the best-performing triple-junction perovskite/Si tandem solar cell thus far. To achieve this, the team engineered a new cyanate-integrated perovskite solar cell that is stable and energy efficient.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Bayer pays $310M to buy into BridgeBio heart drug
BioPharma Drive: Drug Pricing
MARCH 4, 2024
The deal gives the German pharma partial rights to a closely watched medicine for transthyretin amyloidosis cardiomyopathy that analysts expect to become a multibillion-dollar product.
Pets Bring People Big Mental Health Boost: Poll
Drugs.com
MARCH 4, 2024
MONDAY, March 4, 2024 -- The vast majority (84%) of Americans with pets say their animal companion brings a positive mental health impact to their lives, a new poll shows. The poll of more than 2,200 adults conducted early last month also found.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Webb unlocks secrets of one of the most distant galaxies ever seen
Science Daily: Pharmacology News
MARCH 4, 2024
Looking deeply into space and time, astronomers have studied the exceptionally luminous galaxy GN-z11, which existed when our 13.8 billion-year-old universe was only about 430 million years old.
??Sitosterol attenuates anlotinib resistance in non?small cell lung cancer cells by inhibiting miR?181a?3p/SHQ1 signaling
Chemical Biology and Drug Design
MARCH 4, 2024
A549 cells were treated with different concentrations of anlotinib to create anlotinib-resistant A549 cells (A549/anlotinib cells). miR-181a-3p mimics were transfected into A549/anlotinib cells. Meanwhile, A549 and A549/anlotinib cells were treated with β-sitosterol at different concentrations. Cell Counting Kit-8 (CCK-8) was used to measure cell proliferation.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
More Trending
Toddlers Fixated on Screens Talk Less With Parents
Drugs.com
MARCH 4, 2024
MONDAY, March 4, 2024 -- Using TVs and tablets as "e-babysitters" really cuts down on the time toddlers spend interacting with parents or other caregivers, new research shows. The Australian team of investigators are calling the phenomenon.
26th International Conference of the Redox Medicine Society Set for June 2024 in Paris, France
SCIENMAG: Medicine & Health
MARCH 4, 2024
The Redox Medicine Society (RMS) is pleased to announce the 26th International Conference of the Redox Medicine, taking place from June 27 to June 28, 2024, in Paris, France.
One Leafy Green Needs Refrigeration to Prevent E.Coli
Drugs.com
MARCH 4, 2024
MONDAY, March 4, 2024 -- Salad lovers, take note: Lettuce is more vulnerable to E. coli contamination than other leafy greens, researchers report.The physical composition of green leaf and romaine lettuce makes it a happy home for E.
Antarctica's coasts are becoming less icy
Science Daily: Pharmacology News
MARCH 4, 2024
Scientists found unexpected evidence the area of polynyas around Antarctica is increasing dramatically, and it follows an intriguing cycle, growing and shrinking roughly every 16 years.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Vaccines Protect You & Your Kids From Measles: FDA
Drugs.com
MARCH 4, 2024
MONDAY, March 4, 2024 -- As new outbreaks of measles -- a once nearly eliminated illness in the United States -- continue to emerge, experts remind Americans that there's an easy way to stop infection: Get vaccinated."Measles spreads so easily that.
Humans have driven the Earth's freshwater cycle out of its stable state
Science Daily: Pharmacology News
MARCH 4, 2024
New analysis shows that the global freshwater cycle has shifted far beyond pre-industrial conditions.
First Birth Control Pill, Opill, Sold Over the Counter Hits Store Shelves Soon
Drugs.com
MARCH 4, 2024
MONDAY, March 4, 2024 -- The first over-the-counter birth control pill will soon be available in U.S. stores and online, the drug's maker plans to announce Monday. Sold as Opill, the medication was first approved by the U.S. Food and Drug.
Researchers closing in on genetic treatments for hereditary lung disease, vision loss
SCIENMAG: Medicine & Health
MARCH 4, 2024
PORTLAND, Ore. – Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss. Credit: Oregon State University PORTLAND, Ore.
Deliver Fast, Flexible Clinical Trial Insights with Spotfire
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
First Birth Control Pill Sold Over the Counter Hits Store Shelves Soon
Drugs.com
MARCH 4, 2024
MONDAY, March 4, 2024 -- The first over-the-counter birth control pill will soon be available in U.S. stores and online, the drug's maker plans to announce Monday.Sold as Opill, the medication was first approved by the U.S. Food and Drug.
Small and overlooked: Amount of repetitive DNA in blood hints at cancer early
SCIENMAG: Medicine & Health
MARCH 4, 2024
FOR IMMEDIATE RELEASE People with cancer have different amounts of a type of repetitive DNA — called Alu elements — than people without cancer. Now, machine learning can measure that from a blood draw.
More Evidence Sleep Apnea Harms Thinking, Memory
Drugs.com
MARCH 4, 2024
MONDAY, March 4, 2024 -- Sleep apnea could have detrimental effects on the brain, causing memory or thinking problems, a new study suggests.People suffering from sleep apnea are about 50% more likely to also report having memory or thinking.
Nocion, chasing GSK, pulls in $62M for chronic cough drug
BioPharma Drive: Drug Pricing
MARCH 4, 2024
Nocion will use the cash to start a mid-stage trial testing its medicine, a potential rival to a drug GSK acquired last year in a $2 billion deal.
Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Yogurt Makers Can Make Limited Claims About Type 2 Diabetes Prevention: FDA
Drugs.com
MARCH 4, 2024
MONDAY, March 4, 2024 -- Yogurt makers can now make limited claims about the food's power to help prevent type 2 diabetes, the U.S. Food and Drug Administration says.In a statement released Friday, the agency said it will not object to "qualified.
Akero strengthens MASH drug’s case with new study data
BioPharma Drive: Drug Pricing
MARCH 4, 2024
The updated results show that responses to the drug, which is currently in late-stage testing, deepened with time, helping the company rebound from an earlier setback.
1 in 8 Seniors Who Undergo Surgery Are Back in Hospital Within a Month
Drugs.com
MARCH 4, 2024
MONDAY, March 4, 2024 -- Major surgery is a dicey proposition for many seniors, with a substantial number landing back in the hospital just weeks or months after their operation, a new study warns.Nearly one in eight seniors (12%) who undergo.
Sweating the Small Stuff: 20 years of NIOSH Research on Engineering Controls for Nanotechnology
NIOSH Science Blog: Drugs
MARCH 4, 2024
Engineered nanomaterials are intentionally produced substances that have at least one primary dimension less than 100 nanometers (nm). Nanomaterials may have properties different from those of larger particles of the same material, making them unique and desirable for specific product applications (e.g., cosmetics, electronics, construction materials).
New Insights Into the Persistent Pain of UTIs
Drugs.com
MARCH 4, 2024
MONDAY, March 4, 2024 -- People with recurring urinary tract infections frequently have persistent pain, even after antibiotics have cleared the harmful bacteria from their system.Now, researchers have figured out why this perplexing problem.
Protecting joints from bacteria with mussels
SCIENMAG: Medicine & Health
MARCH 4, 2024
Degenerative arthritis is no longer exclusive to the elderly population. According to the National Health Insurance Service report covering the years from 2012 to 2022, there has been a 22.8% increase in the prevalence of degenerative arthritis among people in their 20s and 30s.
AstraZeneca’s drug pricing lawsuit dismissed by federal judge
BioPharma Drive: Drug Pricing
MARCH 4, 2024
The rejection is the latest setback in the pharmaceutical industry’s efforts to use the courts to challenge Medicare’s new pricing powers.
Proceed with caution – the meteoric rise of zero-alcohol drinks
SCIENMAG: Medicine & Health
MARCH 4, 2024
New research from Flinders University has revealed that parents are feeling conflicted, confused and concerned when it comes to zero-alcohol beer, wine and spirts and adolescents. Credit: Flinders University New research from Flinders University has revealed that parents are feeling conflicted, confused and concerned when it comes to zero-alcohol beer, wine and spirts and adolescents.
Looking Back at Black History Month
BenchSci
MARCH 4, 2024
This blog post is co-authored by Black@BenchSci ERG leads, Zena Teferi and Temisan Iwere As Black History Month comes to a close, we want to share some of our internal employee programming highlights, learnings, and reflections from throughout the month. This year, we’re anchoring our Employee Resource Group (ERG) programming around three foundational pillars: Career, Community, and Culture.
Navigating Snaplogic Integration: A Beginner’s Guide
Perficient: Drug Development
MARCH 4, 2024
As there is rapid growth in businesses going digital, the need to develop scalable and reliable functionalities to connect applications, Cloud environments, on-premises assets have grown. To resolve these complex scenarios, iPaaS seems to be a perfect solution. For example, if a developer needs to connect and transfer huge data from an e-commerce platform to a CRM system, writing custom code to handle data transfer would be tedious.
Which pharmaceutical companies have the most emulsion dosed drugs?
Drug Patent Watch
MARCH 4, 2024
This chart shows the pharmaceutical companies with the most emulsion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most emulsion dosed drugs… The post Which pharmaceutical companies have the most emulsion dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
Why, Who, When, Where and More: New Draft Guidance on Notifying FDA about Discontinuance or Interruption in Manufacturing
FDA Law Blog: Biosimilars
MARCH 4, 2024
By Véronique Li, Senior Medical Device Regulation Expert & Deborah L. Livornese — On February 6, 2024, FDA issued a draft guidance titled Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Under Section 506C of the FD&C Act. The draft guidance provides recommendations for applicants and manufacturers about the requirements for notifications about production changes of certain finished drugs and biological products
New patent for Eli Lilly drug OLUMIANT
Drug Patent Watch
MARCH 4, 2024
Annual Drug Patent Expirations for OLUMIANT Olumiant is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are… The post New patent for Eli Lilly drug OLUMIANT appeared first on DrugPatentWatch - Make Better Decisions.
How Can Real-world Data Benefit Your Trials?
Crucial Data Solutions
MARCH 4, 2024
Clinical trial data is coming from more places than ever. It can be collected directly from patients via native and. The post How Can Real-world Data Benefit Your Trials? appeared first on Crucial Data Solutions.
New patent for Bayer Hlthcare drug KERENDIA
Drug Patent Watch
MARCH 4, 2024
Annual Drug Patent Expirations for KERENDIA Kerendia is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There is one patent… The post New patent for Bayer Hlthcare drug KERENDIA appeared first on DrugPatentWatch - Make Better Decisions.
Let's personalize your content